nocloprost

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2000
01219882000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Pretreatment with sucralfate is known to protect gastric mucosa against the damaging effect of strong irritants, and this… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1993
1993
The pharmacokinetics and absolute bioavailability of nocloprost, a synthetic PGE2-analogue with cytoprotective properties, was… (More)
  • figure 1
  • table 1
Is this relevant?
1993
1993
The possible influence of 9 beta-chloro-16,16-dimethyl prostaglandin E2 (nocloprost) on the effect of 137Cs gamma irradiation was… (More)
Is this relevant?
1993
1993
UNLABELLED The effects of the E2 prostaglandin nocloprost (9b-chloro-16,16-dimethyl-prostaglandin E2) on esophageal motility and… (More)
Is this relevant?
1993
1993
Interactions of the cytoprotective agent nocloprost (9 beta-chloro-16,16-dimethyl-prostaglandin E2, CAS 79360-43-3) with the… (More)
Is this relevant?
1992
1992
Pretreatment with aluminium-containing antacids at their original pH or after acidification is known to protect the gastric… (More)
Is this relevant?
1991
1991
Nocloprost (9 beta-chloro-16,16-dimethyl prostaglandin E2 (PGE2)) was examined for gastroprotective and ulcer-healing activity… (More)
Is this relevant?
1991
1991
Previous studies in animals and humans demonstrated that nocloprost, a stable prostaglandin E2 analogue, shows very high… (More)
Is this relevant?
1991
1991
Ten healthy young male subjects took part in a double-blind, placebo-controlled crossover study to assess the effects of… (More)
Is this relevant?
1988
1988
Nocloprost was administered to 3 groups of 4 pregnant guinea pigs intravenously and subcutaneously in a dose of 30 micrograms/kg… (More)
Is this relevant?